# Compass Therapeutics, Inc.: Form 8-K, filed Jun 30, 2021

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2021-06-30
- Accepted by EDGAR: Jun 30, 2021, 13:42 ET
- Period: 2021-06-25
- Accession: 0000950170-21-000411
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000095017021000411/cmpx-20210625.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000095017021000411/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000095017021000411/cmpx-20210625.htm

Filed Jun 30, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-000411. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
